Sightful Invest
  • Business
  • Investing
  • Politics
  • Stock
Top Posts
House Freedom Caucus bid to censure Democrat over...
Popular TP-Link routers could be banned after risks...
Trump signs off on possible CIA operations in...
Senate unanimously passes Epstein files bill, sends to...
DAVID MARCUS: What Ro Khanna told me about...
Trump official fires back at Dem’s Epstein donor...
Scathing report calls on US to label Islamist...
Nancy Mace to force censure vote against fellow...
Rubio orders restitution for hundreds of staffers denied...
Federal judge calls Comey indictment into question, asks...
  • Business
  • Investing
  • Politics
  • Stock

Sightful Invest

Politics

FDA chief counsel who defended abortion pill under Biden resigns 2 days into job

by admin March 13, 2025
March 13, 2025
FDA chief counsel who defended abortion pill under Biden resigns 2 days into job

The Food and Drug Administration’s (FDA) top lawyer, who was appointed to the position just this week, has resigned, according to a Thursday morning post on X.

‘Hilary K. Perkins has resigned from her position as Chief Counsel of FDA, effectively immediately,’ the FDA’s official X account posted.  

Perkins – a former assistant director under Biden’s Department of Justice (DOJ) in the consumer protection agency – was selected on Tuesday by acting general Sean Keveney in the Department of Health and Human Services (HHS) as part of a ‘reorganization’ effort by the department, according to an HHS news release.

She previously defended abortion pill access in a high-profile case under Biden’s DOJ, and HHS officials were reportedly unhappy with the decision to appoint Perkins but were overruled by White House officials, according to a report from Axios this week.

‘We’ve been able to recruit higher quality personnel to HHS than in any time in its history,’ HHS Secretary Robert F. Kennedy, Jr., said in a statement Tuesday at the announcement of Perkins’ assignment on Tuesday. ‘These are individuals who will return the agency to gold-standard science, evidence-based medicine, and recalibrate its trajectory toward public health rather than industry profiteering.’

Fox News Digital has reached out to the HHS and FDA for comment.

This is a breaking story, check back for updates.

This post appeared first on FOX NEWS

previous post
Brian Leni: Latest Mining Stock Wins and How I’m Deploying Cash Now
next post
Senate Republicans coin ‘Schumer shutdown’ ahead of critical vote on Trump spending bill

You may also like

Morning Glory: What if Israelis could vote in...

September 24, 2024

Key Trump agency facing ‘unprecedented backlog’ inherited from...

April 15, 2025

Trump says ‘real chance for greatness’ as Netanyahu...

September 29, 2025

Trump announces more nominations, including Devin Nunes, Troy...

December 15, 2024

Supreme Court signals support for Biden administration regulation...

October 10, 2024

Polish conservative Karol Nawrocki wins presidential election to...

June 2, 2025

Tired of Ukraine? Remember South Vietnam

December 3, 2024

Senate hopefuls jostle for high-stakes seat after Blackburn...

August 7, 2025

Flashlight, rifle, backpacks: Prosecutors outline Ryan Routh’s alleged...

September 13, 2025

It’s not the economy, stupid. Democrats’ real path...

September 3, 2025

Recent Posts

  • House Freedom Caucus bid to censure Democrat over Epstein links goes down in flames
  • Popular TP-Link routers could be banned after risks exposed
  • Trump signs off on possible CIA operations in Venezuela: report
  • Senate unanimously passes Epstein files bill, sends to Trump’s desk
  • DAVID MARCUS: What Ro Khanna told me about his party’s future and Biden’s 20M illegals

    Sign up for our newsletter to receive the latest insights, updates, and exclusive content straight to your inbox! Whether it's industry news, expert advice, or inspiring stories, we bring you valuable information that you won't find anywhere else. Stay connected with us!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Categories

    • Business (951)
    • Investing (3,465)
    • Politics (4,229)
    • Stock (4)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: sightfulinvest.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 Sightful Invest. All Rights Reserved.